10745731001

β-Galactosidase

EIA grade

• Synonym(s): β galactosidase, β-galactosidase
• Enzyme Commission number: 3.2.1.23 (BRENDA, IUBMB)
• UNSPSC Code: 12352204

Properties

• biological source: Escherichia coli
• Quality Level: 100
• Assay: (single peak, HPLC)
• form: lyophilized
• specific activity: 750-950 U/mg
• mol wt: 540.000 kDa
• packaging: pkg of 25 mg (approx. 100 mg lyophilizate)
• manufacturer/tradename: Roche
• technique(s): enzyme immunoassay: suitable
• color: white
• pH: 7.3-7.7
• solubility: water: 20 mg/mL
• λmax: 405
• suitability: suitable for immunoassay
• NCBI accession no.: WP_050940144
• UniProt accession no.: P00722; ; ; ; P00722
• application(s): life science and biopharma
• shipped in: dry ice
• storage temp.: −20°C (−15°C to −25°C)
• Gene Information: Escherichia coli ... lacZ(945006)

Description

General description

β-Galactosidase, EIA grade, is a lyophilizate from E. coli overproducer, consisting of enzyme protein, phosphate buffer, and sucrose. Substances which could interfere with the derivatization of NH₂ or SH groups (e.g., 2-mercaptoethanol, ammonium salts, primary amines etc.) have been removed.

The GLB1 (β-Galactosidase) gene is mapped to human chromosome 3p22.3. The encoded protein belongs to glycosyl hydrolase 35 family and is localized to lysosomes.

Application

β-Galactosidase has been used as a standard to determine the absolute quantitation of LacZ protein.

β-Galactosidase is used for labeling enzyme immunoassay techniques. β-Galactosidase can be coupled to other proteins via its SH-groups. The reconstituted solution can be used directly for conjugation without prior dialysis or gel permeation chromatography.

Biochem/physiol Actions

β-Galactosidase catalyzes the hydrolysis of terminal β-galactose residue of ganglioside substrates, such as glycoproteins, sphingolipids, and keratan sulfate and other glycoconjugates. This enzyme is associated with the mechanism of cell senescence and carcinogenesis. Mutations in the gene result in gangliosidosis, an autosomal recessive disorder, characterized with defective lysosomal storage due to accumulation of substrates. β-Galactosidase deficiency also causes Morquio B syndrome indicating skeletal abnormalities, short stature and increased excretion of keratan sulfate in urine.

Quality

Purity: single peak (HPLC)

Sequence

Free Thiol Groups
The non-denatured, enzymatically-active preparation contains > 12 SH groups per molecule which are not involved in disulfide bridges and are freely accessible to coupling reagents in aqueous media (as assayed with Ellman′s reagent at +37 °C, acc. to Habeeb, 1972).

Absence of Enzyme Aggregates
The preparation contains < 3% dimers (HPLC, area %) and essentially no higher oligomers.

Physical form

Lyophilizate, stabilized with phosphate buffer and sucrose. Note: Contains at least 12 free SH-groups/enzyme molecule; 5 mg approximately 20 mg lyophilizate; 25 mg approximately 100 mg lyophilizate.

Storage and Stability

Store at -15–-25 °C. (sealed under nitrogen)

Analysis Note

Specific activity: approximately 750 - 950 U/mg enzyme protein ≅ approximately 150 - 250 U/mg lyophilizate (+37°C, 2-nitrophenyl-β-D-galactoside); approximately 250-400 U/mg enzyme protein ≅ approximately 60-100 U/mg lyophilizate (+37°C, 4-nitrophenyl-β-D-galactoside).

Other Notes

For life science research only. Not for use in diagnostic procedures.

Safety Information

• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 1
• Flash Point(F): does not flash
• Flash Point(C): does not flash